SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-24-002270
Filing Date
2024-04-26
Accepted
2024-04-26 07:30:12
Documents
14
Period of Report
2024-04-24
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_042624.htm   iXBRL 8-K 30064
2 EXHIBIT 4.1 exh_41.htm EX-4.1 96110
  Complete submission text file 0001171843-24-002270.txt   326958

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE apto-20240424.xsd EX-101.SCH 3009
4 XBRL LABEL FILE apto-20240424_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE apto-20240424_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT f8k_042624_htm.xml XML 3706
Mailing Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3
Business Address 251 CONSUMERS ROAD SUITE 1105 TORONTO A6 M2J 4R3 647-479-9828
Aptose Biosciences Inc. (Filer) CIK: 0000882361 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A6 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-32001 | Film No.: 24878662
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)